BMS-196085 is an orally active, potent and selective full agonist against human β 3 adrenergic receptor with a K i value of 21 nM. BMS-196085 also has partial agonist activity at the β 1 receptor . BMS-196085 is promising for research of obesity and type-II diabetes.
Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Adrenergic Receptor
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.